Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03318939
Brief Title: Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

First Submitted : October 10, 2017
First Submitted that Met QC Criteria : October 20, 2017
First Posted : October 24, 2017

Last Update Submitted that Met QC Criteria : July 23, 2019
Last Update Posted : July 25, 2019